secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001606498-25-000019
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avanos Medical at JP Morgan conference; no specific financial metrics disclosed in available text
--------------------------------------------------------------------------------

- Presentation by Interim CEO Michael Greiner at 43rd Annual JP Morgan Healthcare Conference on January 13, 2025.
- Exhibit text is truncated; only introductory remarks are visible, no numerical results or guidance provided.
- No changes to previously disclosed business plans or objectives were noted in the incomplete text.
- Filing is under Regulation FD; presentation is furnished, not filed, per standard practice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649825000019/0001606498-25-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649825000019/avns-20250113.htm
  HTML page:      https://secwatch.observer/filing/0001606498-25-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer